Search

everythinglearnresearchcommunity

for

Search:↓

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

Inflammation and Demodex mites might contribute to hair loss, and targeting them could help treat it.

Bacteria in our hair can affect its health and growth, and studying these bacteria could help us understand hair diseases better.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Frontal fibrosing alopecia may be linked to genital Lichen sclerosus through an autoimmune process.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Herbs might help with hair loss, but more research is needed to confirm their safety and effectiveness.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

A rare combination of halo nevi, nonsegmental vitiligo, and early gray hair can occur together.

The document says that there are treatments for hair and nail diseases.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

Diphenylcyclopropenone is effective for treating alopecia areata but has a high relapse rate.

Down Syndrome patients with Alopecia Areata often have hypothyroidism and specific immune abnormalities.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

A 5-year-old boy with alopecia totalis had temporary hair regrowth with treatment but relapsed, highlighting the need for thorough investigation and holistic care.

The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

The exam tested knowledge on various skin-related topics for CME credit.

The document concludes that treatments like oral anti-androgens, minoxidil, and topical spironolactone can be effective for hair loss in men and women.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

The combined treatment improved scalp health in women with early-stage hair loss.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

Type 3 Innate Lymphoid Cells help maintain skin health and balance, and are involved in skin diseases and healing.